Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 186

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 14
Chunk 186
---
     /s/ Alexander Tokman Acting Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) March 31, 2025Alexander Tokman         /s/ Richard Jacroux Chief Financial Officer (Principal Financial and Accounting Officer) March 31, 2025Richard Jacroux         /s/ Louis J. Basenese Director March 31 2025Louis J. Basenese         /s/ Anthony DiGiandomenico Director March 31, 2025Anthony DiGiandomenico         /s/ Michael Harsh Director March 31, 2025Michael Harsh    

 68